Biopharma's stock market winners of 2022 revealed

Pipeline performers including Lilly, Daiichi and Sarepta topped the stock market gainers last year, as the Covid trade was thoroughly unwound.

2023 Brand Entertainment Awards winners revealed

Tricida Evaluate

Evaluate Search

Biopharma firms suffer W55tr loss in market cap in 2022

2022 drug approvals: Biopharma delivered 34 new drugs

Pharma-biotech partnerships take on new urgency as patent cliffs

The 10 highest value R&D projects in biopharma

Evaluate Search

Madrigal Pharmaceuticals

Biotech Stocks for investors and traders • BioPharmCatalyst